Jaap Goudsmit
Affiliations: | Virology | University of Amsterdam, Amsterdam, Netherlands |
Area:
retrovirologyWebsite:
http://www.albumacademicum.uva.nl/cgi/b/bib/bib-idx?submit=Sort;sort=datumbenoeming;type=simple;lang=en;c=ap;rgn1=entirerecord;q1=goudsmit;x=7;y=7;cc=ap;view=reslist;fmt=long;page=reslist;size=1;start=2Google:
"Jaap Goudsmit"Parents
Sign in to add mentorJan van der Noordaa | grad student | 1982 | Amsterdam | |
(The human papovavirus BK: natural history and pathogenesis in man) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
van Dongen MJP, Kadam RU, Juraszek J, et al. (2019) A small-molecule fusion inhibitor of influenza virus is orally active in mice. Science (New York, N.Y.). 363 |
Sutton TC, Lamirande EW, Bock KW, et al. (2017) In vitro neutralization is not predictive of prophylactic efficacy of broadly neutralizing monoclonal antibodies CR6261 and CR9114 against lethal H2 influenza virus challenge in mice. Journal of Virology |
Pascual G, Wadia JS, Zhu X, et al. (2017) Immunological memory to hyperphosphorylated tau in asymptomatic individuals. Acta Neuropathologica |
Cox F, Kwaks T, Brandenburg B, et al. (2016) HA Antibody-Mediated FcγRIIIa Activity Is Both Dependent on FcR Engagement and Interactions between HA and Sialic Acids. Frontiers in Immunology. 7: 399 |
Impagliazzo A, Milder F, Kuipers H, et al. (2015) A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen. Science (New York, N.Y.). 349: 1301-6 |
Roos A, Roozendaal R, Theeuwsen J, et al. (2015) Protection against H5N1 by multiple immunizations with seasonal influenza vaccine in mice is correlated with H5 cross-reactive antibodies. Vaccine. 33: 1739-47 |
Otterstrom JJ, Brandenburg B, Koldijk MH, et al. (2014) Relating influenza virus membrane fusion kinetics to stoichiometry of neutralizing antibodies at the single-particle level. Proceedings of the National Academy of Sciences of the United States of America. 111: E5143-8 |
Friesen RH, Lee PS, Stoop EJ, et al. (2014) A common solution to group 2 influenza virus neutralization. Proceedings of the National Academy of Sciences of the United States of America. 111: 445-50 |
Brandenburg B, Koudstaal W, Goudsmit J, et al. (2013) Mechanisms of hemagglutinin targeted influenza virus neutralization. Plos One. 8: e80034 |
Baden LR, Walsh SR, Seaman MS, et al. (2013) First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001). The Journal of Infectious Diseases. 207: 240-7 |